TKK Symphony Prices Upsized $220 million SPAC
by Kristi Marvin on 2018-08-16 at 8:52am

TKK Symphony Acquisition Corporation announced the pricing of their $220 million SPAC this morning and the unit will begin trading today under the symbol TKKSU.

TKK Symphony intends to focus on consumer and lifestyle companies in the PRC and is being led by Mr. Sing Wang, as Chairman and CEO.

Total 2018 deal count is now 28 SPACs with $6.83 billion in total gross proceeds raised.

Congratulations to all.

EarlyBirdCapital, Inc., acted as sole book running manager and I-Bankers Securities, Inc. acted as co-manager of the offering.

 

TKK Symphony Prices Upsized $220 million SPAC
Recent Posts
by Nicholas Alan Clayton on 2025-06-26 at 4:52pm

Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...

by Nicholas Alan Clayton on 2025-06-26 at 8:24am

At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....

by Nicholas Alan Clayton on 2025-06-25 at 6:30pm

Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...

by Nicholas Alan Clayton on 2025-06-25 at 12:44pm

Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...

by Kristi Marvin on 2025-06-25 at 8:37am

CEO Marc Nemati and Colombier II’s Omeed Malik break down the deal and the strategy. Despite its moniker as the “the everything store” you can’t buy everything on Amazon, and firearms are one of those things. But, GrabAGun has spent years building a platform for regulated online firearms purchases, and soon, consumers will be able...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved